Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in News & Analysis

Starna and Recorna Team Up to Discover RNA Drugs for Lung Diseases
Decheng Capital Files for $700 Million Global Life Sciences Fund
Clover Says Bivalent Vaccine Shows Promise for Elderly in Phase I RSV Trial
FutureGen Out-licenses TL1A Antibody to AbbVie in $1.7 Billion Deal
Asieris Says ReviR Identifies Candidates to Modulate Oncogenic Driver Gene
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital